Fu-Chang Hu
www.international-harvard.com.tw
0000-0002-9060-0506
International-Harvard Statistical Consulting Company (iHSCC)
2 papers found
Refreshing results…
Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis
Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves’ Disease: A Pilot Study
Missing publications? Search for publications with a matching author name.